GlassScriptPhysician profile
Paul B Brock
NPI 1790845048
$1,278.60
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10.97 · 2020: $158 · 2021: $41.59 · 2022: $612 · 2023: $263 · 2024: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $595.36 | 2020-2024 | Da Vinci Surgical System |
| Becton, Dickinson and Company | $178.30 | 2023-2024 | Phasix Mesh, Arista Ah Flexitip |
| Stryker Corporation | $172.46 | 2021-2023 | 1688 |
| Davol INC. | $109.08 | 2022-2023 | Phasix Mesh |
| Innocoll Pharmaceuticals Limited | $37.64 | 2022 | |
| Aroa Biosurgery Incorporated | $36.53 | 2024 | |
| Leica Microsystems INC. | $33.66 | 2022 | |
| Merck Sharp & Dohme LLC | $30.90 | 2021-2022 | |
| Intra-Sana Laboratories | $24.33 | 2023 | Glycate, Reltone 400 Mg, Reltone 200 Mg |
| Olympus America INC. | $17.77 | 2022 | |
| Ethicon US, LLC | $16.34 | 2020 | |
| Smith+Nephew, INC. | $15.26 | 2022 | |
| Checkpoint Surgical, INC | $10.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Brock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.